Compare HNST & QTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HNST | QTRX |
|---|---|---|
| Founded | 2012 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 292.9M | 337.7M |
| IPO Year | 2021 | 2017 |
| Metric | HNST | QTRX |
|---|---|---|
| Price | $2.68 | $7.28 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 4 | 3 |
| Target Price | $5.63 | ★ $10.33 |
| AVG Volume (30 Days) | ★ 5.3M | 770.4K |
| Earning Date | 11-05-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.06 | N/A |
| Revenue | ★ $383,117,000.00 | $130,203,000.00 |
| Revenue This Year | $6.68 | N/A |
| Revenue Next Year | $4.81 | $37.03 |
| P/E Ratio | $44.24 | ★ N/A |
| Revenue Growth | ★ 3.89 | N/A |
| 52 Week Low | $2.31 | $4.05 |
| 52 Week High | $8.87 | $13.01 |
| Indicator | HNST | QTRX |
|---|---|---|
| Relative Strength Index (RSI) | 41.20 | 74.28 |
| Support Level | $2.43 | $5.83 |
| Resistance Level | $2.66 | $5.79 |
| Average True Range (ATR) | 0.16 | 0.43 |
| MACD | 0.04 | 0.23 |
| Stochastic Oscillator | 57.29 | 92.50 |
The Honest Co Inc is a digitally-native consumer products company to makes purpose-driven consumer products designed for all people. It is an omnichannel brand, ensuring its products are available wherever its consumers shop through the company's Retail and Digital channels. It has three product categories namely; Diapers and Wipes, Skin and Personal Care, and Household and Wellness, out of which the majority of its revenue is generated from the sale of diapers and wipes. The company operates only in the United States.
Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory and others. Geographically, It operates in North America, EMEA and Asia Pacific.